This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ala-Cpn10, Chaperonin-10, Cpn10
Description: INV103 is a modified version of chaperonin 10. Chaperonin 10 has been shown to be a regulator of the innate immune system as it is released by activated or damaged cells in response to danger signals. Additionally, it down-regulates inflammatory immune responses.
Pink Sheet Chart: FDA Recalls -- May 6, 2009
Scrip Inverseon Inc.
Additional information available to subscribers only: